MEDICAL TRANSCRIPTION BLG CO - COM (MTBC)

CUSIP: 58464J105

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
691,604
Share change
+421,245
Total reported value
$2,301,000
Price per share
$3.32
Number of holders
12
Value change
+$1,432,814
Number of buys
7
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 58464J105?
CUSIP 58464J105 identifies MTBC - MEDICAL TRANSCRIPTION BLG CO - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDICAL TRANSCRIPTION BLG CO - COM (MTBC) as of Q1 2018

As of 31 Mar 2018, MEDICAL TRANSCRIPTION BLG CO - COM (MTBC) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 691,604 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, MACQUARIE GROUP LTD, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, A.R.T. Advisors, LLC, Virtu Financial LLC, QCI ASSET MANAGEMENT INC/NY, BURNS J W & CO INC/NY, and BANK OF AMERICA CORP /DE/. This page lists 12 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.